A placebo-controlled study of three agomelatine dose regimens (10 mg, 25 mg, 25–50 mg) in patients with major depressive disorder
Autor: | Kennedy, Sidney H., Avedisova, Alla, Giménez-Montesinos, Natalia, Belaïdi, Carole, Christian de, Bodinat |
---|---|
Zdroj: | In European Neuropsychopharmacology April 2014 24(4):553-563 |
Databáze: | ScienceDirect |
Externí odkaz: |